WithdrawnNot Applicable

Goal-directed Labor Epidural Analgesia Maintenance

Stopped: Study is currently on hold, pending further evaluation and coordination.

United States0Started 2022-06-01

Plain-language summary

The GLEAM trial is a multicenter, pragmatic, cluster-randomized trial to assess the effects of programmed intermittent epidural bolus versus continuous epidural infusion on the rate of spontaneous vaginal delivery and several other clinically-relevant outcomes.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Requests labor epidural analgesia requiring epidural maintenance with local anesthesia and opioid for planned vaginal delivery Exclusion Criteria: * Planned cesarean delivery * Planned operative vaginal delivery * Epidural time (placement to delivery) \< 1 hour

What they're measuring

Spontaneous Vaginal Delivery

Timeframe: Delivery

Trial details

NCT IDNCT05255263

SponsorUniversity of California, San Francisco

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-06-01

View on ClinicalTrials.gov More Labor Onset and Length Abnormalities trials